The purpose of this Series is to provide up-to-date information on the OECD activities related to testing and assessment of chemicals.
The OECD welcomed a Memorandum of Understanding (MOU) between the Guangdong Provincial Centre for Disease Control and Prevention and the OECD which will support China’s efforts in chemicals regulation and policy making.
This new Advisory Document provides clarity for test facilities on the expectations of national Good Laboratory Practice (GLP) compliance monitoring authorities regarding how test items are transported, received, identified, labelled, sampled, handled, stored, characterised, archived and disposed according to the Principles of OECD GLP.
Ten years ago, OECD started to develop tools to avoid market monopoly as far as possible, to avoid abusive situations and to maintain transparency in OECD Test Guidelines containing Intellectual Property (IP) elements. Find out how the OECD address protected elements in OECD Test Guidelines.
The series on endocrine disrupters provides common tools and guidances for testing the effects of endocrine disrupting chemicals on the oestrogen, androgen and thyroid hormone systems. Using these validated methodologies, regulatory authorities can use internationally harmonised tools to evaluate chemicals of concern for human health and the environment.
The 2018 update of the OECD endocrine disrupting chemicals brochure is now available. The brochure explains why and how OECD became a key player on the issue of endocrine disrupters testing and assessment over the last two decades. It also provides background on endocrine disrupters, and outlines major achievements.
AOP-Wiki version 2.2 contains a large number of new features including multiple navigational tips, the redesign of the AOP pages, the update of the snapshot format to match the new AOP Users' handbook and a new format (AOP-XML) allowing the users to obtain all AOP-Wiki content in an easily usable form. AOP-Wiki users are encouraged to follow our new AOP Users' Handbook providing practical instructions on AOP development.
GLP issues raised by testing labs are covered in this comprehensive list of questions and answers, recently updated with questions related to: sponsors, Contract Research Organisations (CROs), sub-contractors, archives, Information Technology (IT), Biotechnology/GMOs and other miscellaneous issues
Deadlines for comments: Draft Guidance Document on Good In Vitro Method Practices (GIVIMP) for the Development and Implementation of In Vitro Methods for Regulatory Use in Human Safety Assessment by 28 February 2018.
Deadlines for comments of OECD Guideline For The Testing Of Chemicals. Repeated Dose 90-Day Oral Toxicity Study in Rodents by 21 February.